golf, if there is a takeover by HL, the first thing to happen is for Lu to resign. We may not be notified of his departure because of its sensitive and confidential nature until Don is ready to make an announcement of it all.

I see no reason for HL to take on more debt to buyout RVX when they already are licenced to pursue RVX-208 (Apabetalone) on their own. And if that is the case, Resverlogix shareholders would benefit in the process.

I would say that HL is as anxious as the resat of us, waiting to see what become of the FDA Breakthrough Therapy Designation for Apabetalone in combination with top standard of care. I'm not sure they would be in a hurry to take RVX over at this point in time.    

IMO...Koo